<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01025973</url>
  </required_header>
  <id_info>
    <org_study_id>09-110</org_study_id>
    <nct_id>NCT01025973</nct_id>
  </id_info>
  <brief_title>Evaluation and Validation of New Biomarkers by Mass Spectrometry</brief_title>
  <acronym>DG7</acronym>
  <official_title>A New Approach by Mass Spectrometry for Evaluation and Validation of New Biomarkers of Fetus and Mother</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will perform biochemical and metabolic evaluations on cord blood, venous
      blood of the mother and urine of the foetus and mother using time-of-flight and tandem mass
      spectrometry. The investigators could evaluate, dose and validate gestational diabetes
      mellitus biomarkers of the fetus and mother.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Foetal HbA1c</measure>
    <time_frame>At delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Foetal acetylated Hb</measure>
    <time_frame>At delivery</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">99</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Diabetes Mellitus</arm_group_label>
    <description>Patients with type 1, type 2 or gestational diabetes mellitus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal pregnancy</arm_group_label>
    <description>Patient without diabetes mellitus</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine, whole blood, cord blood, plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women with or without diabetes and their newborn.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        For women:

          -  Aged 18 or more

          -  24 weeks of gestation or more

          -  Type 1, type 2 or gestational diabetes mellitus for group 1

          -  Without diabetes for group 2.

        For newborn:

          -  37 weeks of gestation or more

          -  Birth weight 2500 g or more

        Exclusion Criteria:

          -  Multiple birth
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc Ardilouze, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Sherbrooke</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre de recherche clinique Etienne-Le Bel du CHUS</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2009</study_first_submitted>
  <study_first_submitted_qc>December 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2009</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université de Sherbrooke</investigator_affiliation>
    <investigator_full_name>Jean-Luc Ardilouze</investigator_full_name>
    <investigator_title>Endocrinologist, researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>Article</doc_id>
      <doc_type>Clinical Study Report</doc_type>
      <doc_url>https://doi.org/10.2337/dc14-0549</doc_url>
      <doc_comment>Glycation of Fetal Hemoglobin Reflects Hyperglycemia Exposure In Utero Felix O. Dupont1, Marie-France Hivert1,2,3, Catherine Allard1, Julie Ménard1, Patrice Perron1,2, Luigi Bouchard1,4,5, Julie Robitaille6, Jean-Charles Pasquier1,7, Christiane Auray-Blais1,8 and Jean-Luc Ardilouze1,2⇑
+ Author Affiliations
Corresponding author: Jean-Luc Ardilouze, jean-luc.ardilouze@usherbrooke.ca. F.O.D. and M.-F.H. contributed equally to this study.
Diabetes Care 2014 Oct; 37(10): 2830-2833. https://doi.org/10.2337/dc14-0549</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

